Premature ventricular contraction epidemiology and demographics

Premature ventricular contraction Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Premature Ventricular Contraction from other Disorders
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Premature ventricular contraction epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Premature ventricular contraction epidemiology and demographics
CDC onPremature ventricular contraction epidemiology and demographics
Premature ventricular contraction epidemiology and demographics in the news
Blogs on Premature ventricular contraction epidemiology and demographics
to Hospitals Treating Premature ventricular contraction epidemiology and demographics
Risk calculators and risk factors for Premature ventricular contraction epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2] Homa Najafi, M.D.[3]

Overview

The prevalence of premature ventricular contractions (PVCs) varies between 100 to 400 per 100,000 individuals worldwide on standard 12-lead electrocardiography and 4000 to 7500 per 100,000 individuals on 24- to 48-hour Holter monitoring. Patients of all age groups may develop PVC and the incidence increases with age. African- American individuals are more likely to develop PVCs. Men are more commonly developed the disease than women.

Epidemiology and Demographics

Prevalence

• The prevalence of PVCs varies between 100 to 400 per 100,000 individuals worldwide on standard 12-lead electrocardiography and 4000 to 7500 per 100,000 individuals on 24- to 48-hour Holter monitoring.

Age

• Patients of all age groups may develop PVC.
• The incidence of PVCs increases with age.

Race

• African- American individuals are more likely to develop PVCs.

Gender

• Men are more commonly developed PVCs than women.